T. Rowe Price Associates’s Pfizer PFE Stock Holding History

T. Rowe Price Associates’s Portfolio PFE Stock Details PFE Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$273M	Sell	11,252,439 -10,363,057	-48%	-$251M	0.03%	375
2025 Q1	$548M	Buy	21,615,496 +2,743,107	+15%	+$69.5M	0.07%	259
2024 Q4	$501M	Sell	18,872,389 -2,084,603	-10%	-$55.3M	0.06%	269
2024 Q3	$606M	Buy	20,956,992 +3,865,041	+23%	+$112M	0.07%	249
2024 Q2	$478M	Sell	17,091,951 -8,048,018	-32%	-$225M	0.06%	277
2024 Q1	$698M	Sell	25,139,969 -5,404,088	-18%	-$150M	0.09%	211
2023 Q4	$879M	Sell	30,544,057 -18,470,625	-38%	-$532M	0.12%	168
2023 Q3	$1.63B	Buy	49,014,682 +16,418,085	+50%	+$545M	0.24%	90
2023 Q2	$1.2B	Sell	32,596,597 -4,401,435	-12%	-$161M	0.17%	124
2023 Q1	$1.51B	Buy	36,998,032 +1,125,491	+3%	+$45.9M	0.23%	93
2022 Q4	$1.84B	Sell	35,872,541 -595,448	-2%	-$30.5M	0.3%	77
2022 Q3	$1.6B	Buy	36,467,989 +1,529,779	+4%	+$66.9M	0.26%	73
2022 Q2	$1.83B	Sell	34,938,210 -404,839	-1%	-$21.2M	0.23%	92
2022 Q1	$1.83B	Sell	35,343,049 -7,915,667	-18%	-$410M	0.18%	110
2021 Q4	$2.55B	Buy	43,258,716 +4,065,502	+10%	+$240M	0.23%	87
2021 Q3	$1.69B	Buy	39,193,214 +14,898,367	+61%	+$641M	0.16%	129
2021 Q2	$951M	Buy	24,294,847 +1,026,903	+4%	+$40.2M	0.09%	243
2021 Q1	$843M	Sell	23,267,944 -8,284,042	-26%	-$300M	0.08%	248
2020 Q4	$1.16B	Sell	31,551,986 -8,189,202	-21%	-$301M	0.12%	183
2020 Q3	$1.46B	Sell	39,741,188 -7,795,316	-16%	-$286M	0.17%	127
2020 Q2	$1.55B	Sell	47,536,504 -3,325,693	-7%	-$109M	0.2%	106
2020 Q1	$1.66B	Sell	50,862,197 -8,379,703	-14%	-$274M	0.26%	76
2019 Q4	$2.32B	Sell	59,241,900 -214,567	-0.4%	-$8.41M	0.3%	68
2019 Q3	$2.14B	Sell	59,456,467 -33,930,387	-36%	-$1.22B	0.3%	73
2019 Q2	$4.05B	Sell	93,386,854 -13,694,054	-13%	-$593M	0.57%	30
2019 Q1	$4.55B	Sell	107,080,908 -3,127,601	-3%	-$133M	0.67%	25
2018 Q4	$4.81B	Buy	110,208,509 +22,112,635	+25%	+$965M	0.81%	18
2018 Q3	$3.88B	Buy	88,095,874 +13,512,864	+18%	+$596M	0.57%	26
2018 Q2	$2.71B	Buy	74,583,010 +9,611,686	+15%	+$349M	0.41%	48
2018 Q1	$2.31B	Buy	64,971,324 +2,970,051	+5%	+$105M	0.37%	61
2017 Q4	$2.25B	Sell	62,001,273 -149,318	-0.2%	-$5.41M	0.36%	61
2017 Q3	$2.22B	Buy	62,150,591 +2,514,747	+4%	+$89.8M	0.38%	60
2017 Q2	$2B	Sell	59,635,844 -13,653,403	-19%	-$459M	0.36%	62
2017 Q1	$2.51B	Sell	73,289,247 -7,611,894	-9%	-$260M	0.47%	41
2016 Q4	$2.63B	Sell	80,901,141 -12,416,237	-13%	-$403M	0.52%	35
2016 Q3	$3.16B	Sell	93,317,378 -16,166,741	-15%	-$548M	0.64%	26
2016 Q2	$3.85B	Sell	109,484,119 -26,788,246	-20%	-$943M	0.82%	18
2016 Q1	$4.04B	Buy	136,272,365 +23,830,548	+21%	+$706M	0.86%	16
2015 Q4	$3.63B	Buy	112,441,817 +7,753,429	+7%	+$250M	0.76%	20
2015 Q3	$3.29B	Buy	104,688,388 +3,176,728	+3%	+$99.8M	0.73%	21
2015 Q2	$3.4B	Buy	101,511,660 +13,406,903	+15%	+$450M	0.7%	23
2015 Q1	$3.07B	Buy	88,104,757 +179,948	+0.2%	+$6.26M	0.63%	24
2014 Q4	$2.74B	Buy	87,924,809 +7,349,872	+9%	+$229M	0.58%	28
2014 Q3	$2.38B	Sell	80,574,937 -3,134,462	-4%	-$92.7M	0.52%	42
2014 Q2	$2.48B	Sell	83,709,399 -21,348,962	-20%	-$634M	0.54%	35
2014 Q1	$3.37B	Sell	105,058,361 -1,788,393	-2%	-$57.4M	0.76%	15
2013 Q4	$3.27B	Sell	106,846,754 -9,156,891	-8%	-$280M	0.75%	12
2013 Q3	$3.33B	Buy	116,003,645 +1,571,653	+1%	+$45.1M	0.83%	11
2013 Q2	$3.21B	Buy	+114,431,992	New	+$3.21B	0.86%	9